Royalty Pharma PLC (RPRX)
NASDAQ:RPRX
Holding RPRX?
Track your performance easily

Royalty Pharma (RPRX) Financial Statements

1,185 Followers

Royalty Pharma Financial Overview

Royalty Pharma's market cap is currently ―. The company's EPS TTM is $2.556; its P/E ratio is 10.31; and it has a dividend yield of 3.17%. Royalty Pharma is scheduled to report earnings on February 12, 2025, and the estimated EPS forecast is $1.00. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 537.27M$ 567.98M$ 596.07M$ 536.31M$ 538.20M
Gross Profit$ 537.27M$ 567.98M$ 596.07M$ 536.31M$ 538.20M
EBIT$ 243.39M$ 39.96M$ 764.84M$ 122.08M$ 398.29M
EBITDA$ 243.39M$ 39.96M$ 764.84M$ 122.08M$ 398.29M
Net Income Common Stockholders$ 151.02M$ 4.78M$ 494.34M$ 72.11M$ 274.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.80B$ 872.00M$ 495.31M$ 941.75M$ 2.18B
Total Assets$ 17.66B$ 16.13B$ 16.38B$ 15.86B$ 17.12B
Total Debt$ 7.60B$ 6.14B$ 6.14B$ 6.13B$ 7.13B
Net Debt$ 5.80B$ 5.27B$ 5.64B$ 5.19B$ 4.95B
Total Liabilities$ 7.90B$ 6.27B$ 6.30B$ 6.27B$ 7.31B
Stockholders Equity$ 6.48B$ 6.50B$ 6.53B$ 6.14B$ 6.28B
Cash Flow-
Free Cash Flow$ 658.21M$ 664.64M$ 772.63M$ 573.52M$ 607.82M
Operating Cash Flow$ 658.21M$ 664.64M$ 772.63M$ 573.52M$ 607.82M
Investing Cash Flow$ -893.18M$ -86.65M$ -1.00B$ -450.66M$ -63.43M
Financing Cash Flow$ 1.16B$ -212.00M$ -231.89M$ -1.36B$ -347.00M
Currency in USD

Royalty Pharma Earnings and Revenue History

Royalty Pharma Debt to Assets

Royalty Pharma Cash Flow

Royalty Pharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis